Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450
References (27)
- et al.
J. Allergy clin. Immun.
(1974) - et al.
J. Allergy clin. Immun.
(1977) Pharmac. Ther.
(1977)- et al.
Biochem. Pharmac.
(1979) - et al.
Biochem. Pharmac.
(1972) - et al.
Archs. Biochem. Biophys.
(1975) Biochimie
(1978)- et al.
Biochem. Pharmac.
(1976) - et al.
Biochem. Pharmac.
(1981) - et al.
Biochem. Pharmac.
(1976)
J. biol. Chem.
(1964)
Ann. Sclavo
(1973)
Cited by (101)
Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromatase
2008, Biochemical PharmacologyCitation Excerpt :While the 455–460 nm peak is usually considered to reflect the interaction of carbene, an uncharged reactive intermediate, with the iron [30]. Therefore, the 455–460 nm peak of type III binding spectrum is thought to reflect the formation of P450 metabolic–intermediate complex [30,32–34]. We observed this novel binding spectrum in the aromatase–DBF complex in the absence of NADPH-P450 reductase and NADPH.
The paradoxical effect of acetaminophen on CYP3A4 activity and content in transfected HepG2 cells
2002, Archives of Biochemistry and BiophysicsHuman, rat and crocodile liver microsomal monooxygenase activities measured using diazepam and nifedipine: Effects of CYP3A inhibitors and relationship to immunochemically detected CYP3A apoprotein
1999, Comparative Biochemistry and Physiology - C Pharmacology Toxicology and EndocrinologyPig hepatocytes as an in vitro model to study the regulation of human CYP3A4: Prediction of drug-drug interactions with 17α-ethynylestradiol
1997, Chemico-Biological InteractionsRole of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity
1997, Toxicology and Applied PharmacologyChromatographic separation and behavior of microsomal cytochrome P450 and cytochrome b<inf>5</inf>
1996, Journal of Chromatography B: Biomedical Applications
Copyright © 1981 Published by Elsevier Inc.